Voyager Therapeutics, Inc.
COMPOSITIONS AND METHODS OF TREATING HUNTINGTON'S DISEASE
Last updated:
Abstract:
The present invention relates to adeno-associated viral (AAV) particles encoding siRNA molecules and methods for treating Huntington's Disease (HD).
Status:
Application
Type:
Utility
Filling date:
21 Sep 2018
Issue date:
3 Dec 2020